Elderly patients with locally advanced head and neck squamous cell carcinoma treated with NBTXR3 nanoparticles activated by radiotherapy: A phase I trial

被引：0
|
作者：
Le Tourneau, C. [1 ]
Calugaru, V. [1 ]
Moreno, V. [2 ]
Mirabel, X. [3 ]
Dodger, B. [2 ]
Calvo, E. [2 ]
Jouffroy, T. [1 ]
Rodriguez, J. [1 ]
Chilles, A. [1 ]
Yemi, M. [1 ]
Hoffmann, C. [1 ]
机构：
[1] Inst Curie, Med Oncol, Paris, France
[2] Fdn Jimenez Diaz, Univ Hosp, Med Oncol Start Madrid FJD, Madrid, Spain
[3] Oscar Lambret Ctr, Med Oncol, Lille, France
来源：
ANNALS OF ONCOLOGY | 2018年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1058P
引用
收藏
页数：2
相关论文
共 50 条
  • [21] A phase I study of fludarabine combined with radiotherapy in patients with intermediate to locally advanced head and neck squamous cell carcinoma
    Grégoire, V
    Ang, KK
    Rosier, JF
    Beauduin, M
    Garden, AS
    Hamoir, M
    Hittelman, WN
    Humblet, Y
    Khuri, FR
    Milas, L
    Mitine, C
    Scalliet, P
    [J]. RADIOTHERAPY AND ONCOLOGY, 2002, 63 (02) : 187 - 193
  • [22] Phase I study of NBTXR3 activated by radiotherapy in patients with advanced cancers treated with an anti-PD-1 therapy.
    Shen, Colette
    Frakes, Jessica
    Weiss, Jared
    Caudell, Jimmy J.
    Hackman, Trevor G.
    Akulian, Jason A.
    El-Haddad, Ghassan
    Hu, Yun
    Dixon, Robert
    Pearson, Alexander T.
    Barsoumian, Hampartsoum B.
    Cortez, Maria Angelica
    Jameson, Katherine LaRoque
    Said, Patricia
    Welsh, James William
    Seiwert, Tanguy Y.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [23] A phase I-II trial of gefitinib (IRESSA) and radiotherapy in patients with locally advanced inoperable squamous cell carcinoma of the head and neck (SCCHN)
    Caponigro, F.
    Franchin, G.
    Rav, V.
    Silvestro, G.
    Morrica, B.
    Romano, C.
    Minatel, E.
    Pepe, S.
    [J]. EJC SUPPLEMENTS, 2005, 3 (02): : 313 - 313
  • [24] Phase I/II trial of NBTXR3 activated by SBRT in patients with hepatocellular carcinoma or liver metastasis
    Pracht, M.
    Chajon, E.
    Rolland, Y.
    de Baere, T.
    Nguyen, F.
    Bronowicki, J-P.
    Vendrely, V.
    Cunha, A. Sa
    Baumann, A-S.
    Croise-Laurent, V.
    Rio, E.
    Said, P.
    Le Sourd, S.
    Gustin, P.
    Perret, C.
    Peiffert, D.
    Deutsch, E.
    [J]. ANNALS OF ONCOLOGY, 2019, 30
  • [25] NBTXR3 activated by SBRT combined with nivolumab or pembrolizumab in advanced cancers: phase I trial
    Vivar, O.
    Shen, C.
    Frakes, J.
    Niu, J.
    Rosenberg, A.
    Weiss, J.
    Caudell, J.
    Jameson, K.
    Said, P.
    Seiwert, T.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S28 - S28
  • [26] Durvalumab with cetuximab and radiotherapy for locally advanced squamous cell carcinoma of the head and neck: A phase 1/2 trial
    Bonomo, Pierluigi
    Desideri, Isacco
    Mangoni, Monica
    Saieva, Calogero
    Loi, Mauro
    Becherini, Carlotta
    Cerbai, Cecilia
    Ganovelli, Michele
    Salvestrini, Viola
    Stocchi, Giulia
    Zani, Margherita
    Palomba, Annarita
    Livi, Lorenzo
    [J]. RADIOTHERAPY AND ONCOLOGY, 2022, 169 : 64 - 70
  • [27] Hypofractionated radiotherapy combined with cetuximab in vulnerable elderly patients with locally advanced head and neck squamous cell carcinoma
    De Felice, Francesca
    Vetrone, Luigia
    Bulzonetti, Nadia
    Caiazzo, Rossella
    Marampon, Francesco
    Musio, Daniela
    Tombolini, Vincenzo
    [J]. MEDICAL ONCOLOGY, 2019, 36 (08)
  • [28] Hypofractionated radiotherapy combined with cetuximab in vulnerable elderly patients with locally advanced head and neck squamous cell carcinoma
    Francesca De Felice
    Luigia Vetrone
    Nadia Bulzonetti
    Rossella Caiazzo
    Francesco Marampon
    Daniela Musio
    Vincenzo Tombolini
    [J]. Medical Oncology, 2019, 36
  • [29] Radiotherapy and chemotherapy in locally advanced head and neck squamous cell carcinoma
    Krstevska, V.
    [J]. JOURNAL OF BUON, 2009, 14 (03): : 361 - 373
  • [30] Radiotherapy for the management of locally advanced squamous cell carcinoma of the head and neck
    Ko, C.
    Citrin, D.
    [J]. ORAL DISEASES, 2009, 15 (02) : 121 - 132
12345